Valley National Advisers’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Valley National Advisers's DGX Position: Q2 2026 in Review
Valley National Advisers reduced its Quest Diagnostics (DGX) stake by 2.5% in Q2 2026, selling an estimated $1.18K and leaving 232 shares worth $49.2K. The position accounts for 0.01% of the portfolio, ranked #416.
Valley National Advisers first reported a position in DGX in Q4 2018 and has held it in 19 quarters since. The position peaked at $750K in Q4 2022. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Valley National Advisers held 232 shares of Quest Diagnostics worth $49.2K as of Q2 2026.
- Valley National Advisers sold 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
- Quest Diagnostics made up 0.01% of Valley National Advisers's portfolio in Q2 2026, its #416 holding.
- Valley National Advisers first reported a position in Quest Diagnostics in Q4 2018 and has held it in 19 quarters since.
- Valley National Advisers's Quest Diagnostics position peaked at $750K in Q4 2022.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.